Health Score

0 Excellent

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Attach ORCID iDs across 33 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact33 DOIs

Add abstracts to 1 article

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact1 DOIs

Deposit reference lists for 1 record

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact1 DOIs

DOIs for this ISSN

Showing the top 5 of 71 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	What's in a Word? Falsified/Counterfeit/Fake Medicines - The… (10.5301/maapoc.0000008)	ORCID	31.38	17
2	Timeline of Authorization and Reimbursement for Oncology Dru… (10.5301/maapoc.0000007)	ORCID	30.76	16
3	The Critical Role of the Clinical Research Coordinator for C… (10.5301/maapoc.0000015)	ORCID	27.85	12
4	Unveiling the Peril of Substandard and Falsified Medicines t… (10.5301/maapoc.0000023)	ORCID	26.03	10
5	Improving market access to rare disease therapies: A worldwi… (10.1177/2399202618810121)	ORCID	23.86	8
6	The advantages of electronic patient-reported measures and a… (10.1177/2399202618813463)	ORCID	23.86	8
7	Medicines Counterfeiting in Africa: A View from… (10.5301/maapoc.0000017)	ORCID	23.86	8
8	Medicines Regulatory Harmonization: International Collaborat… (10.5301/maapoc.0000001)	ORCID	22.58	7
9	Access to Oncology Drugs in Brazil: Juggling Innovation and… (10.5301/maapoc.0000004)	ORCID	22.58	7
10	Access to Highly Purified Chondroitin Sulfate for Appropriat… (10.5301/maapoc.0000022)	ORCID	22.58	7
11	Health diagnosis improvement in remote community health cent… (10.1177/2399202617753101)	ORCID	21.13	6
12	Initiatives driving accelerated access to medicines in Europ… (10.1177/2399202618761854)	ORCID	21.13	6
13	Earlier Patient Access – the UK Early Access to Medicines Sc… (10.5301/maapoc.0000009)	ORCID	21.13	6
14	The EU Falsified Medicines Directive: Key Implications for… (10.5301/maapoc.0000024)	ORCID	21.13	6
15	From Off-Label to Repurposed Drug in Non-Oncological Rare Di… (10.5301/maapoc.0000016)	ORCID	19.45	5
16	Ethical Crossroads: Expanded Access, Patient Advocacy, and t… (10.5301/maapoc.0000019)	ORCID	19.45	5
17	Medicine Thefts And Their Prevention: Current Approach In It… (10.1177/2399202618768676)	ORCID	17.47	4
18	Post-trial access to treatment: How managed access programs… (10.1177/2399202618795431)	ORCID	17.47	4
19	Unlicensed Medicines in the UK - Legal Frameworks, Risks, an… (10.5301/maapoc.0000006)	ORCID	17.47	4
20	Fighting Counterfeit Medicines in Europe: The Effect on Acce… (10.5301/maapoc.0000010)	ORCID	17.47	4
21	Falsified Medicines Directive: Are We Heading in the Right… (10.5301/maapoc.0000011)	ORCID	17.47	4
22	Innovative Strategy for Counterfeit Analysis (10.5301/maapoc.0000013)	ORCID	17.47	4
23	Amid COVID-19 crisis, pain therapeutics telehealth services… (10.1177/2399202620947035)	ORCID	15.05	3
24	Alternatives When an Authorized Medicinal Product is Not… (10.5301/maapoc.0000005)	ORCID	11.93	2
25	Trends in United States Drug Shortages for Medications Used… (10.5301/maapoc.0000012)	ORCID	11.93	2
26	Publication of Clinical Trials Data: A New Approach to Trans… (10.5301/maapoc.0000018)	ORCID	11.93	2
27	Improving access to post-treatment support for patients with… (10.1177/2399202618786932)	ORCID	7.53	1
28	Access to Optimal Treatment in Head and Neck Cancer: A Patie… (10.5301/maapoc.0000014)	ORCID	7.53	1
29	USA Criminal and Civil Prosecutions Associated with Illicit… (10.5301/maapoc.0000020)	ORCID	7.53	1
30	The top 5 issues in EU medicines policy for 2018 (10.1177/2399202618774510)	ORCID	0.00	0
31	Access to HPV vaccination for boys in the United Kingdom (10.1177/2399202618799691)		0.00	9
32	Compliance to current national medicines law for proper stor… (10.1177/2399202618816900)		0.00	3
33	Sharing knowledge for policy action in low- and middle-incom… (10.1177/2399202619834246)		0.00	4
34	National electrocardiographic mapping by telemedicine for di… (10.1177/2399202619840627)		0.00	0
35	Antibiotics self-medication among undergraduate pharmacy stu… (10.1177/2399202619846847)		0.00	8
36	The state of naloxone: Access amid a public health crisis (10.1177/2399202619847639)		0.00	2
37	Emerging voluntary cooperation between European healthcare s… (10.1177/2399202619852317)		0.00	10
38	Tackling distribution-related shortages of medicines: An Ita… (10.1177/2399202619856859)		0.00	3
39	Patient empowerment and access to medicines: Insights from a… (10.1177/2399202619865167)		0.00	5
40	Patient experiences of access to NCD medicines in Sri Lanka:… (10.1177/2399202619873228)		0.00	9
41	The magnitude of prescribing medicines by brand names at Muh… (10.1177/2399202619900148)		0.00	3
42	Utility of medicines information leaflets in hypertensive ca… (10.1177/2399202620910031)		0.00	3
43	Influencers on deprescribing practice of primary healthcare… (10.1177/2399202620922507)		0.00	20
44	A model to strengthen utility of quality pharmaceutical heal… (10.1177/2399202620940267)		0.00	4
45	A framework for the management of donated medical devices ba… (10.1177/2399202620941367)		0.00	6
46	Evaluation of medication adherence and predictors of sub-opt… (10.1177/2399202620954089)		0.00	5
47	Advancing health system strengthening through improving acce… (10.1177/2399202620962299)		0.00	4
48	Cost savings of paper analytical devices (PADs) to detect su… (10.1177/2399202620980303)		0.00	13
49	Quality assessment of Diflucan<sup>®</sup> tablets distribut… (10.1177/23992026211002089)		0.00	5
50	You Have Options: Implementing and evaluating a contraceptiv… (10.1177/23992026211003499)		0.00	4